Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing's disease
- PMID: 28533356
- PMCID: PMC5510591
- DOI: 10.1530/ERC-17-0131
Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing's disease
Abstract
The CABLES1 cell cycle regulator participates in the adrenal-pituitary negative feedback, and its expression is reduced in corticotropinomas, pituitary tumors with a largely unexplained genetic basis. We investigated the presence of CABLES1 mutations/copy number variations (CNVs) and their associated clinical, histopathological and molecular features in patients with Cushing's disease (CD). Samples from 146 pediatric (118 germline DNA only/28 germline and tumor DNA) and 35 adult (tumor DNA) CD patients were screened for CABLES1 mutations. CNVs were assessed in 116 pediatric CD patients (87 germline DNA only/29 germline and tumor DNA). Four potentially pathogenic missense variants in CABLES1 were identified, two in young adults (c.532G > A, p.E178K and c.718C > T, p.L240F) and two in children (c.935G > A, p.G312D and c.1388A > G, and p.D463G) with CD; no CNVs were found. The four variants affected residues within or close to the predicted cyclin-dependent kinase-3 (CDK3)-binding region of the CABLES1 protein and impaired its ability to block cell growth in a mouse corticotropinoma cell line (AtT20/D16v-F2). The four patients had macroadenomas. We provide evidence for a role of CABLES1 as a novel pituitary tumor-predisposing gene. Its function might link two of the main molecular mechanisms altered in corticotropinomas: the cyclin-dependent kinase/cyclin group of cell cycle regulators and the epidermal growth factor receptor signaling pathway. Further studies are needed to assess the prevalence of CABLES1 mutations among patients with other types of pituitary adenomas and to elucidate the pituitary-specific functions of this gene.
Keywords: Cushing’s disease; corticotropinoma; germline mutation; whole-exome sequencing.
© 2017 The authors.
Figures
Similar articles
-
The Cables1 Gene in Glucocorticoid Regulation of Pituitary Corticotrope Growth and Cushing Disease.J Clin Endocrinol Metab. 2016 Feb;101(2):513-22. doi: 10.1210/jc.2015-3324. Epub 2015 Dec 22. J Clin Endocrinol Metab. 2016. PMID: 26695862
-
The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.J Clin Endocrinol Metab. 2015 Jul;100(7):E997-1004. doi: 10.1210/jc.2015-1453. Epub 2015 May 5. J Clin Endocrinol Metab. 2015. PMID: 25942478 Free PMC article.
-
Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing's Disease With or Without an MEN4 Phenotype.J Clin Endocrinol Metab. 2020 Jun 1;105(6):1983-2005. doi: 10.1210/clinem/dgaa160. J Clin Endocrinol Metab. 2020. PMID: 32232325 Free PMC article.
-
Genetics of Cushing's syndrome.Neuroendocrinology. 2010;92 Suppl 1:6-10. doi: 10.1159/000314215. Epub 2010 Sep 10. Neuroendocrinology. 2010. PMID: 20829611 Review.
-
[Genetic basis of Cushing's disease in children and targeted therapeutic future perspectives].Probl Endokrinol (Mosk). 2020 Dec 11;66(6):39-49. doi: 10.14341/probl12676. Probl Endokrinol (Mosk). 2020. PMID: 33481366 Review. Russian.
Cited by
-
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations.Nat Rev Endocrinol. 2024 May;20(5):278-289. doi: 10.1038/s41574-023-00948-8. Epub 2024 Feb 9. Nat Rev Endocrinol. 2024. PMID: 38336897 Review.
-
Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion.Front Endocrinol (Lausanne). 2023 Jun 14;14:1166076. doi: 10.3389/fendo.2023.1166076. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37388215 Free PMC article.
-
Pituitary Tumorigenesis-Implications for Management.Medicina (Kaunas). 2023 Apr 21;59(4):812. doi: 10.3390/medicina59040812. Medicina (Kaunas). 2023. PMID: 37109772 Free PMC article. Review.
-
Refractory corticotroph adenomas.Pituitary. 2023 Jun;26(3):269-272. doi: 10.1007/s11102-023-01308-5. Epub 2023 Mar 14. Pituitary. 2023. PMID: 36917358 Free PMC article. Review.
-
Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion.medRxiv [Preprint]. 2023 Jan 20:2023.01.20.23284646. doi: 10.1101/2023.01.20.23284646. medRxiv. 2023. Update in: Front Endocrinol (Lausanne). 2023 Jun 14;14:1166076. doi: 10.3389/fendo.2023.1166076. PMID: 36711613 Free PMC article. Updated. Preprint.
References
-
- Cazabat L, Bouligand J, Salenave S, Bernier M, Gaillard S, Parker F, Young J, Guiochon-Mantel A, Chanson P. 2012. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients. Journal of Clinical Endocrinology and Metabolism 97 E663–E670. (10.1210/jc.2011-2291) - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous